% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Weijers:286670,
author = {D. D. Weijers and S. Hirsch$^*$ and J. J. Bakhuizen and N.
van Engelen and L. A. Kester and M. E. G. Kranendonk and L.
S. Hiemcke-Jiwa and E. de Vos-Kerkhof and J. L. C. Loeffen
and R. Autry$^*$ and K. Pajtler$^*$ and N. Jäger$^*$ and M.
C. J. Jongmans and R. P. Kuiper},
title = {{M}olecular analysis of cancer genomes in children with
{L}ynch syndrome: {E}xploring causal associations.},
journal = {International journal of cancer},
volume = {154},
number = {8},
issn = {0020-7136},
address = {Bognor Regis},
publisher = {Wiley-Liss},
reportid = {DKFZ-2024-00034},
pages = {1455-1463},
year = {2024},
note = {2024 Apr 15;154(8):1455-1463},
abstract = {Lynch syndrome (LS) predisposes to cancer in adulthood and
is caused by heterozygous germline variants in a mismatch
repair (MMR) gene. Recent studies show an increased
prevalence of LS among children with cancer, suggesting a
causal relationship. For LS-spectrum (LSS) cancers,
including high-grade gliomas and colorectal cancer,
causality has been supported by typical MMR-related tumor
characteristics, but for non-LSS cancers, causality is
unclear. We characterized 20 malignant tumors of 18 children
with LS, including 16 non-LSS tumors. We investigated second
hits, tumor mutational load, mutational signatures and MMR
protein expression. In all LSS tumors and three non-LSS
tumors, we detected MMR deficiency caused by second hit
somatic alterations. Furthermore, these MMR-deficient tumors
carried driver variants that likely originated as a
consequence of MMR deficiency. However, in 13 non-LSS tumors
$(81\%),$ a second hit and MMR deficiency were absent, thus
a causal link between LS and cancer development in these
children is lacking. These findings demonstrate that
causality of LS in children with cancer, which can be
determined by molecular tumor characterization, seems to be
restricted to specific tumor types. Large molecular and
epidemiological studies are needed to further refine the
tumor spectrum in children with LS.},
keywords = {Lynch syndrome (Other) / cancer predisposition (Other) /
mismatch repair (Other) / mutational signatures (Other) /
pediatric cancer (Other)},
cin = {B062 / HD01},
ddc = {610},
cid = {I:(DE-He78)B062-20160331 / I:(DE-He78)HD01-20160331},
pnm = {312 - Funktionelle und strukturelle Genomforschung
(POF4-312)},
pid = {G:(DE-HGF)POF4-312},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:38175816},
doi = {10.1002/ijc.34832},
url = {https://inrepo02.dkfz.de/record/286670},
}